Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years)

Human Papillomavirus (HPV) Clinical Trial

Official title:
Survey Study of the Awareness, Acceptance, and Barriers to Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years)

Status Recruiting

Clinical Trial Summary

The objectives of this study are:

1. to determine the degree of understanding and perceived risks for human papillomavirus (HPV) disease, to examine and assess attitudes for personal use of HPV vaccine and identify potential barriers to HPV vaccine access and utilization in a population of young men who have sex with men (MSM) (under 26 years of age)and in parents of boys aged 9 to 18 years

2. to determine HPV vaccine acceptance and predictors of acceptance in a population of young MSM and in patients of boys ages 9 to 18 years

3. to develop strategies to overcome potential barriers to vaccination and improve vaccine access and utilization via development of targeted educational initiatives.

Clinical Trial Description

n/a

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Human Papillomavirus (HPV)

Clinical Trial Details

NCT number	NCT01197079
Study type	Observational
Source	Ann & Robert H Lurie Children's Hospital of Chicago
Contact	Tina Q Tan, MD
Phone	773-880-4187
Email	ttan@northwestern.edu
Status	Recruiting
Phase	N/A
Start date	August 2010
Completion date	August 2011

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02540928` - AMG 319 in HPV Positive and Negative HNSCC	Phase 2
Not yet recruiting	`NCT05727033` - Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections	N/A
Completed	`NCT03111251` - Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics	N/A
Withdrawn	`NCT04849377` - RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC	Phase 2
Completed	`NCT02873741` - New Strategies to Assess Anal Cancer Risk In Women
Completed	`NCT01188850` - Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100	Phase 1
Completed	`NCT02524223` - Prevalence of HPV Transmission During Medically Assisted Procreation Procedures	N/A
Completed	`NCT03180684` - Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)	Phase 2
Recruiting	`NCT05539638` - The Role of Circulating Tumour DNA in Head and Neck Cancer